Hot Watch List: Sangamo Biosciences Inc. (NASDAQ:SGMO), KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), Immersion Corporation (NASDAQ:IMMR), International Bancshares Corporation (NASDAQ:IBOC), United Therapeutics Corporation (NASDAQ:UTHR)

Sangamo Biosciences Inc. (NASDAQ:SGMO) reported a consolidated net loss of $12.1 million, or $0.17 per share, compared to a net loss of $7.0 million, or $0.10 per share, for the same period in 2014. As of June 30, 2015, the Company had cash, cash equivalents, marketable securities and interest receivable of $218.6 million. Sangamo Biosciences Inc. (NASDAQ:SGMO) belongs to Healthcare sector. Its net profit margin is -47.10% and weekly performance is -13.75%. On last trading day company shares ended up $7.59. Sangamo Biosciences Inc. (NASDAQ:SGMO) distance from 50-day simple moving average (SMA50) is -28.94%.

On 29 July, KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug (IND) application for KB003, an anti-GM-CSF monoclonal antibody (mAb), in patients with chronic myelomonocytic leukemia (CMML), and that the IND is now active. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) shares fell -1.48% in last trading session and ended the day at $2.00. KBIO return on assets is -79.40%. KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) quarterly performance is -50.00%.

On 30 July, Immersion Corporation (NASDAQ:IMMR) reported Total revenues for the second quarter of 2015 were $16.2 million, an increase of 37% compared to $11.8 million for the second quarter of 2014. Royalty and license revenues of $15.9 million for the second quarter of 2015 were up 37% from the same period last year. Net income for the second quarter of 2015 was $1.6 million, or $0.06 per diluted share. This compares to net income of $169 thousand, or $0.01 per diluted share, for the second quarter of 2014. On 06 August, Immersion Corporation (NASDAQ:IMMR) shares fell -1.11% and was closed at $12.47. IMMR EPS growth in last 5 year was 16.40%. Immersion Corporation (NASDAQ:IMMR) year to date (YTD) performance is 31.68%.

International Bancshares Corporation (NASDAQ:IBOC) ended the last trading day at $27.23. Company weekly volatility is calculated as 1.97% and price to cash ratio as 6.50. International Bancshares Corporation (NASDAQ:IBOC) showed a weekly performance of 1.30%.

United Therapeutics Corporation (NASDAQ:UTHR) announced that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company’s business at the 2015 Wedbush PacGrow Healthcare Conference in New York City. The presentation will take place on Tuesday, August 11, 2015, at 9:10 AM Eastern Time. United Therapeutics Corporation (NASDAQ:UTHR) shares fell -4.14% in last trading session and ended the day at $159.65. UTHR Gross Margin is 93.10% and its return on assets is 9.10%. United Therapeutics Corporation (NASDAQ:UTHR) quarterly performance is -7.55%.

Leave a Reply

Your email address will not be published. Required fields are marked *